Sixteen new investigator award (NIA) winners are receiving up to $10,000 in grants from the American Association of Colleges of Pharmacy.
A large single-payer administrative claims database was used to assess the economic impact of switching from metoprolol to nebivolol for the treatment of hypertension.
A patient-centric approach to medications is the key to identifying drug therapy problems.
A satisfactory system for the collection and reporting of adverse events is increasingly important as manufacturers place additional requirements on their specialty pharmacy and health care provider partners, and these needs go beyond the United States.
This study evaluates the impact of patient cost sharing on the probability of receiving disease-modifying therapies and treatment compliance among patients with multiple sclerosis.
Oliceridine (Olinvyk) expands options for managing moderate to severe acute pain, but cost, drug-drug interactions, and other factors come into play.
Telehealth is a cost-saving solution that uses telecommunications technologies to expand health care outside the walls of a retail pharmacy while complementing and enhancing existing retail pharmacy services.
American pharmacies across the nation are struggling as a result of pharmacy benefit manager (PBM) practices.
Erlotinib may confer an economic advantage for payers over docetaxel and pemetrexed for second-line treatment of lung cancer because of lower costs.
This analytic model assessed the per-woman cost differences between the use of 2 levonorgestrel-releasing intrauterine devices, from a US payer perspective.
Pharmacy students are sharing thoughts about the prospective job market and pharmacist oversupply.
Increased technician involvement also improves patient care nationwide.
This article details what pharmacists need to know about the FDA's new proposed rule on pregnancy and lactation labeling.
Although naloxone delivery devices are proven to reduce opioid overdoses, challenges persist in increasing the use of these devices in the community setting.
The bigger question is how patients can use that information to positively affect their lives.
For patients with psoriasis and/or psoriatic arthritis, actual-to-expected dosing ratios and costs were lower for etanercept than for ustekinumab.
Specialty pharmacies have multiple decisions to make for clinical programs that accompany a contract with a manufacturer.
Throughout their years in pharmacy school, almost all students have been asked, “What do you want to do after graduation?”
I have just begun my 41st year as a pharmacy educator, and I can truthfully admit that I enjoy what I do as much as or more today than at any other time during my professional career.
This Continuing Education activity is supported by educational funding provided by Amgen and Novartis Pharmaceuticals Inc.
Results from Eisai Inc's online national survey of cancer patients, published in the 2012 Eisai Oncology Digest, highlight financial concerns of cancer treatment and their impact on treatment adherence.
Competition is heating up in the specialty marketplace as investment capital is drawn in and the pharmaceutical industry shifts from traditional brand-name drugs to specialty drugs over the next few years.
Asembia is great not only for networking conversations that can lead to transactions but also for taking stock of your organization.
Examination of pharmacy behaviors before and after implementation indicated that restrictions in pharmacy benefits may not deter utilization for Part D.